菜籽粕制备复合氨基酸螯合铜的工艺优化

发酵工艺已成功开发并用于生产大部分必需氨基酸,但蛋氨酸却是例外.尽管已经尝试利用微生物法生产蛋氨酸,但至今未能实现商业化生产.本文详细讨论了大肠杆菌、棒状杆菌和短杆菌等有潜在产蛋氨酸能力的菌株体内的蛋氨酸生物合成调节机制,阐述了微生物发酵法产蛋氨酸的研究进展,对蛋氨酸发酵生产的发展前景进行了展望.     

大肠杆菌MetD运输系统缺失对蛋氨酸积累的影响

【目的】构建MetD运输系统缺失突变株,研究该运输系统功能缺失对Escherichia coli W3110蛋氨酸吸收和积累的影响。【方法】通过RT-qPCR比较MetJ阻遏调控解除菌株和野生株E.coli metNIQ表达量的变化,并分析蛋氨酸吸收速度的变化;利用Red同源重组系统分别敲除metNIQ基因簇、metN、metI和metQ,构建MetD运输功能缺失的突变株,研究蛋氨酸吸收速度的变化及对蛋氨酸积累的影响。【结果】MetJ阻遏调控解除后,metNIQ的表达量和蛋氨酸吸收速度显著增加。通过敲除E.coli W3110和Me05的metNIQ,MetD运输系统缺失导致蛋氨酸吸收速度下降。另外,分别敲除用于产蛋氨酸基座菌株Me06的metNIQ基因簇、metN、metI和metQ。生长曲线和摇瓶发酵结果表明,metI的敲除促进菌体的生长和蛋氨酸的合成,蛋氨酸的产量从0.39 g/L提高到0.45 g/L,提高了15.4%,蛋氨酸产率从0.14 g/g DCW提高到0.15 g/g DCW。【结论】E.coli MetD功能的缺失能够降低蛋氨酸的吸收速度,敲除metNIQ基因簇上的metI能够提高蛋氨酸产量。     

羟基蛋氨酸及其钙盐的合成研究进展

羟基蛋氨酸钙是复方α-酮酸片中一个重要成分,可防止氨基酸缺乏和改善代谢紊乱,对肾功能衰竭具有一定的疗效,并对钙代谢和继发性甲状旁腺功能亢进都具有益作用,同时也是重要的有机合成、药物合成及生物合成中间体.本文对近年来羟基蛋氨酸及其钙盐的合成方法进行了综述.重点介绍了氰醇水解法、蛋氨酸转化法、酮酸转化法、酮醇氧化法、氰代磷酸二乙酯法和α-羟基-γ-丁内酯法等在羟基蛋氨酸及其钙盐合成中的应用.     

富含蛋氨酸玉米醇溶蛋白在大肠杆菌中的表达

目的:克隆玉米中富含蛋氨酸的10kD玉米醇溶蛋白,证明植物源目的基因在大肠杆菌中能够表达.方法:从玉米胚乳中克隆高蛋氨酸基因zein,通过PCR扩增zein片段,连接pGEX - 4T -1原核表达载体,转入大肠杆菌中,IPTG诱导后,HPLC测定蛋氨酸含量.结果:经PCR扩增出467bp条带,Blast分析同源性99%,经IPTG诱导进行SDS - PAGE检测,发现在36kD处出现一条明显的条带.诱导后菌体总蛋氨酸含量比正常菌体提高了9.6%.结论:证实了植物源10kD玉米醇溶蛋白在大肠杆菌中能够表达.     

DL-蛋按酸及衍生物的合成与拆分研究进展

综述了蛋氨基酸及其衍生物的化学合成及化学拆分近年来的研究进展.第一部分讨论了DL-蛋氨酸及其衍生物的化学合成,包括丙烯醛法、丙二酸酯法,氨基内酯法等,并着重介绍了海因法.第二部分为 DL-蛋氨酸的手性拆分,主要包括膜分离,加合物、络合物形式分离,用苯丙氨酸拆分,衍生物分离等拆分方法,还介绍了生物酶拆分方法和其它有关拆分方法的进展.     

蛋氨酸脑啡肽质量标准研究

建立了蛋氨酸脑啡肽的质量标准。采用液相色谱-质谱联用仪检测蛋氨酸脑啡肽分子量和鉴别蛋氨酸脑啡肽的各氨基酸组成,反相高效液相色谱测定蛋氨酸脑啡肽含量。蛋氨酸脑啡肽分子量为573.7,氨基酸组成为Tyr-Gly-Gly-Phe-Met。蛋氨酸脑啡肽质量浓度在7~280 mg/L(r=0.999 8)内线性关系良好,平均回收率为98.54%,RSD为0.89%。所建立的方法科学,可靠,重复性好。可准确地对蛋氨酸脑啡肽进行定性定量检测。     

发酵法生产S-腺苷蛋氨酸前体蛋氨酸补加策略

利用酿酒酵母菌株高密度发酵法生产S-腺苷蛋氨酸关键的影响因素之一是前体L-蛋氨酸的补加策略.本研究采用一支经过常规诱变处理的S-腺苷蛋氨酸优势积累菌株酿酒酵母SAM0801,通过5 L发酵罐高密度发酵实验研究,考察了6种补加策略,最终确定了L-蛋氨酸的加入时机为30h左右,当茵体干重达到100g/L时,补加量为每罐40gL-蛋氨酸,发酵58 h左右达到最高生物量干重168 g/L,产量14.48 g/L.     

60Co-γ射线诱变选育富硒酵母菌株

本试验以产朊假丝酵母菌(Candida utilis)为出发菌株,通过60Co-γ射线诱变,采用Na2SeO3抗性平板初筛和摇瓶培养复筛的方法,获得了一株高硒和高硒蛋氨酸含量的菌株CU7,与出发菌株相比,生物量达到10.58g/L、总硒提高了2.01倍.硒蛋氨酸的含量提高了2.44倍,硒蛋氨酸与总硒的比值也由49.85...     

DL-蛋氨酸及其衍生物的合成与拆分研究进展

综述了蛋氨酸及其衍生物的化学合成及化学拆分近年来的研究进展。第一部分讨论了 DL-蛋氨酸及其衍生物的化学合成 ,包括丙烯醛法 ,丙二酸酯法 ,氨基内酯法等 ,并着重介绍了海因法。第二部分为 DL-蛋氨酸的手性拆分 ,主要包括膜分离 ,加合物、络合物形式分离 ,用苯丙氨酸拆分 ,衍生物分离等拆分方法 ,还介绍了生物酶拆分方法和其它有关拆分方法的进展     

DL-蛋氨酸及其衍生物的合成与拆分研究进展

综述了蛋氨酸及其衍生物的化学合成及化学拆分近年来的研究进展。第一部分讨论了 DL-蛋氨酸及其衍生物的化学合成 ,包括丙烯醛法 ,丙二酸酯法 ,氨基内酯法等 ,并着重介绍了海因法。第二部分为 DL-蛋氨酸的手性拆分 ,主要包括膜分离 ,加合物、络合物形式分离 ,用苯丙氨酸拆分 ,衍生物分离等拆分方法 ,还介绍了生物酶拆分方法和其它有关拆分方法的进展     

Selective oxidation and reduction of methionine residues in peptides and proteins by oxygen exchange between sulfoxide and sulfide

Treatment of amino acids, peptides, and proteins with aqueous solution of dimethyl sulfoxide (Me2SO) and hydrochloric acid (HCl) resulted in the oxidation of methionine to methionine sulfoxide. In addition to methionine, SH groups are also oxidized, but this reaction proceeds after a lag period of 2 h. Other amino acids are not modified by aqueous Me2SO/HCl. The reaction is strongly pH-dependent. Optimal conditions are 1.0 M HCl, 0.1 M Me2SO, at 22 degrees C. The reaction exhibits pseudo-first order kinetics with Kobs = 0.23 +/- 0.015 M-1 min-1 at 22 degrees C. Incubation of methionine sulfoxide with dimethyl sulfide and HCl resulted in the conversion of methionine sulfoxide to methionine. This reaction is fast (t1/2 = 4 min at room temperature) and quantitative at relatively anhydrous condition (i.e. at H2O:concentrated HCl:dimethyl sulfide ratio of 2:20:1). Quantitative conversions of methionine sulfoxide back to methionine are obtained in peptides and proteins as well, with no observable other side reactions in amino acids and proteins. The wide applications of this selective oxidation and reduction of methionine residues are demonstrated and discussed.     

Methionine metabolism in BHK cells: Preliminary characterization of the physiological effects of cycloleucine,an inhibitor of S-adenosylmethionine biosynthesis

Cycloleucine is in vitro a competitive inhibitor of methionine adenosyltransferase, an enzyme involved in S-adenosylmethionine biosynthesis. The physiological effects of this drug on baby hamster kidney cells have been studied. When cells are grown in a medium containing 10 μM methionine, cycloleucine is an inhibitor of cell proliferation; high concentrations of methionine are able to withdraw this inhibition suggesting that cycloleucine toxicity is related to methionine metabolism. The drug does not primarily affect methionine uptake and its subsequent use for protein biosynthesis. Cycloleucine toxicity is correlated with a block of SAM biosynthesis and nucleic acids methylations. The actions of cycloleucine on progression in the cell cycle and DNA, RNA and protein biosynthesis are studied. The implications of these results are discussed.     

Regulation of hepatic betaine-homocysteine methyltransferase by dietary methionine

The hepatic activity of betaine-homocysteine methyltransferase is a complex function of the content of methionine in the diet. Enzyme levels are lower in the livers of rats fed a 0.3% methionine diet than in livers of animals maintained on either methionine-free or excessivemethionine (1.0%) rations. The finding that activities are increased at both extremes of the spectrum of dietary methionine intake suggests the possibility that the betaine-homocysteine methyltransferase reaction may function both to maintain tissue concentrations of methionine when intake of this amino acid is limited and to remove homocysteine when methionine intake is excessive.     

Methionine production by fermentation

Fermentation processes have been developed for producing most of the essential amino acids. Methionine is one exception. Although microbial production of methionine has been attempted, no commercial bioproduction exists. Here, we discuss the prospects of producing methionine by fermentation. A detailed account is given of methionine biosynthesis and its regulation in some potential producer microorganisms. Problems associated with isolation of methionine overproducing strains are discussed. Approaches to selecting microorganism having relaxed and complex regulatory control mechanisms for methionine biosynthesis are examined. The importance of fermentation media composition and culture conditions for methionine production is assessed and methods for recovering methionine from fermentation broth are considered.     

Differential inhibition of glutamine and gamma-glutamylcysteine synthetases by alpha-alkyl analogs of methionine sulfoximine that induce convulsions.

The alpha-methyl and alpha-ethyl analogs of methionine sulfoximine, like methionine sulfoximine, induce convulsions in mice and inhibit glutamine synthetase irreversibly; alpha-ethylmethionine sulfoximine is approximately 50% as inhibitory as methionine sulfoximine and alpha-methylmethionine sulfoximine. However, whereas alpha-methylmethionine sulfoximine and methionine sulfoximine inhibit gamma-glutamylcysteine synthetase markedly, alpha-ethylmethionine sulfoximine does not, nor does administration of the alpha-ethyl analog produce the decrease in tissue glutathione levels found after giving methionine sulfoximine or its alpha-methyl analog. The findings strongly indicate that methionine sulfoximine-induced convulsions are closely associated with inhibition of glutamine synthetase rather than with inhibition of gamma-glutamylcysteine synthetase. The alpha-alkyl methionine sulfoximine analogs cannot be catabolized via the corresponding alpha-keto or alpha-imino acids, and, like other alpha-substituted amino acids, are probably not metabolized to a significant extent in vivo; this suggests that the amino acid sulfoximine molecules themselves, rather than their metabolites, are directly involved in the induction of convulsions. Possible explanations for the reported lack of correlation between the occurrence of convulsions and the levels of glutamine synthetase activity (and its substrates and product) are considered. The findings suggest that studies on the mechanism of induction of convulsions may be extended significantly and refined in biochemical terms by the use of other structurally modified convulsant molecules.     

Enhancing oxidative resistance of Agrobacterium radiobacter N-carbamoyl D-amino acid amidohydrolase by engineering solvent-accessible methionine residues

N-Carbamoyl D-amino acid amidohydrolase (D-NCAase) that catalyzes the stereospecific hydrolysis of N-carbamoyl D-amino acids to their corresponding D-amino acids is valuable in pharmaceutical industry. Agrobacterium radiobacter D-NCAase is sensitive to oxidative damage by hydrogen peroxide. To investigate the role of methionine residues in oxidative inactivation, each of the nine methionine residues in A. radiobacter D-NCAase was substituted with leucine, respectively, by site-directed mutagenesis. Except for two mutants (Met5Leu and Met31Leu) with similar activities, seven mutants (Met73Leu, Met167Leu/Met169Leu, Met184Leu, Met220Leu, Met239Leu, Met244Leu, and Met239Leu/Met244Leu) were found to have reduced activities. In the presence of H(2)O(2), three mutants (Met239Leu, Met244Leu, and Met239Leu/Met244Leu) with substitution of highly solvent-accessible methionines by leucines retained their activities. The other mutants were also considerably resistant to chemical oxidation than was the wild-type enzyme. Thus, substitution of solvent-accessible methionine residues with leucine to enhance oxidative stability of D-NCAase is practical but might be with compromised activity.     

Characteristics and Relationships of Mercury-Resistant Mutants and Methionine Auxotrophs of Yeast

Approximately one-half of the mutants of Saccharomyces cerevisiae that are selected as resistant to methyl mercury are also found to require methionine. Eighty-four percent of these met mutations occur at the met15 locus, and the remaining 16% occur at the met2 locus. Surprisingly, the methionine-requiring mutants are recovered at a much higher frequency on methionineless media than on media supplemented with methionine. Growth patterns of the met mutants on media having a continuous concentration gradient of methionine and mercury compounds indicate that, at a critical concentration of the mercury compounds, the methionine requirement of certain met mutants is partially or completely alleviated. This was found for met2, met15, and to a lesser extent for met6, but not for any other methionine mutants. This loss of methionine requirement is produced with methyl mercury, phenyl mercury, and mercuric chloride although met2 and met15 strains can be shown to be resistant only to methyl mercury. Other methionine auxotrophs are not resistant to any of the three mercury compounds. The met2 and met15 mutants, but not the other methionine auxotrophs, develop a sheen of an unidentified product when grown on media with mercuric chloride but not with methyl mercury or phenyl mercury. It is suggested that met2 and met15 mutants produce a simple diffusible substance, which detoxifies methyl mercury, which reacts with mercuric chloride to produce a sheen, and which is the cause of the methionine requirement.     

Bioengineering approaches to improve the nutritional values of seeds by increasing their methionine content

Methionine is a nutritionally essential, sulfur-containing amino acid found at low levels in plants and in their seeds. Methionine levels often limit the plant’s value as a source of dietary protein for humans and animals. Despite recent accumulated knowledge of methionine metabolism in vegetative tissues, there is still little knowledge of methionine metabolism in seeds. In this review, we summarize the efforts made to increase the levels of methionine in seeds using genetic engineering methods. Two main approaches were tested: the first was the expression of methionine-rich storage proteins in a seed-specific manner, with the goal of trapping the soluble methionine into protein form and competing with the catabolism of methionine to its essential metabolites. However, in many cases this approach does not lead to a significant increase in total methionine content. The second approach aimed to increase the soluble content of methionine in seeds. Despite the nutritional significance of methionine, the factors regulating soluble methionine content in seeds are not fully known. Evidence shows that two biosynthetic pathways, the aspartate family pathway and the S-methylmethionine pathway, contribute to soluble methionine content in seeds. However, their roles in soluble methionine synthesis and accumulation are not fully understood. In recent years, combinations of these two approaches have been tested; however, they have not yet succeeded in elevating total methionine content in seeds. More emphasis should be applied to gaining knowledge of the biosynthesis pathways that could contribute to an increase in methionine content in seeds.     

The determination of methionine in proteins by gas-liquid chromatography.

Intact methionine residues in proteins were rapidly and precisely determined by measuring methyl thiocyanate released during the reaction with CNBr and separated by g.l.c. Conditions for the reaction and for chromatography on columns of Porapak P-S are described. The recovery of methyl thiocyanate from several methionine derivatives and analogues were examined. Carbamoylmethionine was adopted as a stable primary standard and ethyl thiocyanate as internal standard. The measured methionine content of several isolated proteins was close to the theoretical value indicated by previous work and the results for these and a range of food proteins agreed well with results obtained by ion-exchange chromatography after performic acid oxidation. Since CNBr does not react with methionine sulphoxide and a preliminary hydrolysis is not required, the method discriminates between methionine and any methionine sulphoxide that may be present. It could be useful in studies on the nutritional availability of methionine in processed foods.     

Methionine sulfoxide reductase contributes to meeting dietary methionine requirements

Methionine sulfoxide reductases are present in all aerobic organisms. They contribute to antioxidant defenses by reducing methionine sulfoxide in proteins back to methionine. However, the actual in vivo roles of these reductases are not well defined. Since methionine is an essential amino acid in mammals, we hypothesized that methionine sulfoxide reductases may provide a portion of the dietary methionine requirement by recycling methionine sulfoxide. We used a classical bioassay, the growth of weanling mice fed diets varying in methionine, and applied it to mice genetically engineered to alter the levels of methionine sulfoxide reductase A or B1. Mice of all genotypes were growth retarded when raised on chow containing 0.10% methionine instead of the standard 0.45% methionine. Retardation was significantly greater in knockout mice lacking both reductases. We conclude that the methionine sulfoxide reductases can provide methionine for growth in mice with limited intake of methionine, such as may occur in the wild.